Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label Study of Apremilast in Chronic Idiopathic Pruritus

Trial Profile

An Open Label Study of Apremilast in Chronic Idiopathic Pruritus

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2018

At a glance

  • Drugs Apremilast (Primary)
  • Indications Pruritus
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2018 Planned End Date changed from 1 Oct 2018 to 31 Dec 2018.
    • 17 Oct 2018 Planned primary completion date changed from 1 Oct 2018 to 31 Dec 2018.
    • 26 Jun 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top